Cough and Cold Preparations

DrugDrug NameDrug Indication
DB00003Dornase alfaUsed as adjunct therapy in the treatment of cystic fibrosis.
DB00318CodeineFor treatment and management of pain (systemic). It is also used as an antidiarrheal and as a cough suppressant.
DB00742MannitolUsed for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.
DB00868BenzonatateFor the symptomatic relief of cough. Has also been applied locally in the oral cavity in adults by releasing the drug from the liquid-filled capsules to provide oropharyngeal anesthesia for conscious intubation.
DB00874GuaifenesinUsed to assist the expectoration of phlegm from the airways in acute respiratory tract infections.
DB00956HydrocodoneFor relief of moderate to moderately severe pain. Also used for the symptomatic relief of nonproductive cough, alone or in combination with other antitussives or expectorants.
DB01423SteproninStrepronin is a mucolytic (expectorant) drug.
DB01538AcetyldihydrocodeineNot Available
DB03852EucalyptolNot Available
DB04339CarbocisteineUsed to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis.
DB04822OxeladinNot Available
DB04837ClofedanolUsed in the treatment of dry cough.
DB05057ErdosteineFro the treatment of chronic bronchitis in adults.
DB06439TyloxapolUsed as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
DB06742AmbroxolAmbroxol is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport. It promotes mucus clearance, facilitates expectoration and eases productive cough, allowing patients to breathe freely and deeply.
DB06823TioproninTiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization.
DB08939LetosteineNot Available
DB08944IsoaminileNot Available
DB08990EprazinoneNot Available
DB09002CloperastineNot Available
DB09004ClobutinolNot Available
DB09019BromhexineNot Available
DB09209PholcodineFor use as a cough suppressant.
DB11186PentoxyverineNot Available
DB11609NormethadoneFor use in the treatment of cough when other less potent treatments have failed [FDA Label].
DB12472LevodropropizineNot Available
DB13293IpecacuanhaNot Available
DB13735GuaiacolsulfonateNot Available